Cashu
Structure Therapeutics at AACR 2025: Promising Innovations in Cancer Therapies
8 months ago
Stocks
Health Care
gpcr
Structure Therapeutics
NASDAQ: GPCR
+2.06 (+3.09%)
68.8
USD
At close at Dec 10, 21:45 UTC
Overview
Loading chart...
Key Stats
Market Cap
3.84B
Dividend Yield
0.00%
P/E Ratio
-18.23
EPS
-0.86
Revenue
-
Avg. Volume
5.26M
About
What does GPCR do?
Structure Therapeutics, a clinical stage biopharmaceutical company based in South San Francisco, focuses on developing oral therapeutics targeting GPCRs for chronic diseases. It went public on February 3, 2023, and employs 111 people.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.